Transdermal Delivery
Noven Reports First Quarter 2007 Financial Results
Published in Law and Health Weekly, May 19th, 2007
"We're off to a strong start in 2007," said Robert C. Strauss, Noven's President, CEO & Chairman. "Sales of our Vivelle-Dot(R) and Daytrana(TM) products contributed to a 90% increase in first quarter revenues. This increase in revenues, together with a significant improvement in our overall gross margin, contributed to a near ten-fold increase in net income. Additionally, we received during the quarter the first of three potential $25 million milestones related...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP
AARP Launches Statewide Campaign for Health Care Reform - AARP Illinois
AARP Illinois Joins Governor in Fight for Health Care Reform - Addiction Medicine
Cytos Biotechnology enters exclusive license agreement with Novartis to develop, manufacture and commercialize novel vaccine for treatment of nicotine addiction - Addiction Medicine
Review finds ways of helping children of drug and alcohol misusers - Advanced Medical Solutions Group
Proposal for the reduction of the Company's share capital by the cancellation of its Deferred Shares of 5p each and the cancellation of its share premium account - Aging
Women Assuming Primary Caregiving Role as Society Ages - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
